Jasper Therapeutics, Inc. (JSPR) - Quarterly Income Statement

Home
JSPR
Financials

5.7 (USD) • At close June 5, 2025

Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

	2025 Q1	2024 Q4	2024 Q3	2024 Q2	2024 Q1	2023 Q4	2023 Q3	2023 Q2	2023 Q1	2022 Q4	2022 Q3	2022 Q2	2022 Q1	2021 Q4	2021 Q3	2021 Q2	2021 Q1	2020 Q4	2020 Q3	2020 Q2	2020 Q1
Revenue Numbers are in millions	0	1.174	0	0	0	2.052	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cost of Revenue Numbers are in millions	0	0.587	0	0.299	0.288	0.283	0.276	0.377	0.373	0.367	0.358	0.313	0.272	0.23	0.336	0	0	0	0	0	0
Gross Profit Numbers are in millions	0	0.587	0	-0.299	-0.288	1.769	-0.276	-0.377	-0.373	-0.367	-0.358	-0.313	-0.272	-0.23	-0.336	0	0	0	0	0	0
Gross Profit Ratio Numbers are in millions	0	0.5	0	0	0	0.862	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Reseach & Development Expenses Numbers are in millions	16.157	19.772	14.455	11.296	10.298	13.835	14.848	13.297	9.805	9.282	9.022	8.135	8.188	8.657	7.188	5.156	4.42	4.647	4.52	4.776	1.94
General & Administrative Expenses Numbers are in millions	5.645	5.513	5.434	4.697	4.774	3.89	4.514	4.53	4.142	4.465	3.686	3.828	4.59	3.425	2.891	3.262	1.834	1.311	1.488	1.236	0.765
Selling & Marketing Expenses Numbers are in millions	0	0.288	0	0	-0.288	-0.283	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
SG&A Numbers are in millions	5.645	5.801	5.434	4.697	4.486	3.607	4.514	4.53	4.142	4.465	3.686	3.828	4.59	3.425	2.891	3.262	1.834	1.311	1.488	1.236	0.765
Other Expenses Numbers are in millions	0	0.062	0	-0.04	-0.022	-0.118	0.051	-0.109	-0.07	0.301	0	0.089	-0.072	0	0	0.004	0.001	0	0	0	0
Operating Expenses Numbers are in millions	21.802	25.573	19.889	15.993	14.784	17.442	19.362	17.827	13.947	13.747	12.708	11.963	12.778	12.082	10.079	8.418	6.254	5.958	6.008	9.392	1.483
Operating Income Numbers are in millions	-21.802	-25.285	-19.889	-15.993	-15.072	-17.725	-19.362	-17.827	-13.947	-13.747	-12.708	-11.963	-12.778	-12.082	-10.079	-8.418	-6.254	-5.958	-6.008	-6.012	-2.705
Operating Income Ratio Numbers are in millions	0	-21.537	0	0	0	-8.638	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Other Income Expenses Net Numbers are in millions	0	72.233	1.252	1.41	1.344	1.144	1.818	1.747	-0.313	0.536	0.845	1.559	10.571	3.025	6.667	0.004	-3.5	-4.029	-4.817	-3.411	2.802
Income Before Tax Numbers are in millions	0	46.948	-18.637	-14.583	-13.728	-16.581	-17.544	-16.08	-14.26	-13.211	-11.863	-10.404	-2.207	-9.057	-3.412	-8.414	-9.754	-9.987	-10.825	-9.423	-1.434
Income Before Tax Ratio Numbers are in millions	0	39.99	0	0	0	-8.08	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Income Tax Expense Numbers are in millions	0	0.054	0	-0.299	0.245	1.913	-1.709	-1.856	1.652	-0.536	-1.113	-1.559	-10.571	-9.301	-0.132	-0.004	7.001	4.029	4.706	0.001	1.271
Net Income Numbers are in millions	0	46.948	-18.637	-14.583	-13.728	-16.581	-17.544	-16.08	-15.912	-12.675	-10.75	-8.845	8.364	-9.057	-3.412	-8.414	-9.754	-9.987	-10.825	-9.423	-1.434
Net Income Ratio Numbers are in millions	0	39.99	0	0	0	-8.08	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
EPS Numbers are in millions	-1.41	3.22	-1.24	-0.97	-1.03	-1.5	-1.6	-1.47	-1.8	-3.46	-0.29	-0.24	0.23	-1.82	-0.69	-0.22	-0.26	-0.26	-0.29	-16.08	0
EPS Diluted Numbers are in millions	-1.41	3.22	-1.24	-0.97	-1.03	-1.5	-1.6	-1.47	-1.8	-3.46	-0.29	-0.24	0.23	-1.82	-0.69	-0.22	-0.26	-0.26	-0.29	-16.06	0
EBITDA Numbers are in millions	-21.802	45.874	-19.348	-15.694	-14.784	-17.442	-19.086	-17.552	-13.673	-13.474	-12.44	-11.745	-12.562	-11.888	-3.067	-8.389	-6.232	-0.088	-6.008	0	2.573
EBITDA Ratio Numbers are in millions	0	39.075	0	0	0	-8.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Jasper Therapeutics, Inc.

NASDAQ:JSPR Add to watchlist

NASDAQ:JSPR